2025-03-04 2026-03-31 2026-03-31 false 16289601 AP MEDICAL RESCUE LTD 2026-05-19 false iso4217:GBP xbrli:pure 16289601 2025-03-03 16289601 2026-03-31 16289601 2025-03-04 2026-03-31 16289601 2025-03-02 16289601 2025-03-03 16289601 2025-03-03 2025-03-03 16289601 bus:SmallEntities 2025-03-04 2026-03-31 16289601 bus:AuditExempt-NoAccountantsReport 2025-03-04 2026-03-31 16289601 bus:FullAccounts 2025-03-04 2026-03-31 16289601 bus:PrivateLimitedCompanyLtd 2025-03-04 2026-03-31 16289601 core:WithinOneYear 2026-03-31 16289601 core:AfterOneYear 2026-03-31 16289601 core:WithinOneYear 2025-03-03 16289601 core:AfterOneYear 2025-03-03 16289601 core:ShareCapital 2026-03-31 16289601 core:SharePremium 2026-03-31 16289601 core:RevaluationReserve 2026-03-31 16289601 core:OtherReservesSubtotal 2026-03-31 16289601 core:RetainedEarningsAccumulatedLosses 2026-03-31 16289601 core:ShareCapital 2025-03-03 16289601 core:SharePremium 2025-03-03 16289601 core:RevaluationReserve 2025-03-03 16289601 core:OtherReservesSubtotal 2025-03-03 16289601 core:RetainedEarningsAccumulatedLosses 2025-03-03 16289601 core:LandBuildings 2026-03-31 16289601 core:PlantMachinery 2026-03-31 16289601 core:Vehicles 2026-03-31 16289601 core:FurnitureFittings 2026-03-31 16289601 core:OfficeEquipment 2026-03-31 16289601 core:NetGoodwill 2026-03-31 16289601 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 16289601 core:ListedExchangeTraded 2026-03-31 16289601 core:UnlistedNon-exchangeTraded 2026-03-31 16289601 core:LandBuildings 2025-03-03 16289601 core:PlantMachinery 2025-03-03 16289601 core:Vehicles 2025-03-03 16289601 core:FurnitureFittings 2025-03-03 16289601 core:OfficeEquipment 2025-03-03 16289601 core:NetGoodwill 2025-03-03 16289601 core:IntangibleAssetsOtherThanGoodwill 2025-03-03 16289601 core:ListedExchangeTraded 2025-03-03 16289601 core:UnlistedNon-exchangeTraded 2025-03-03 16289601 core:LandBuildings 2025-03-04 2026-03-31 16289601 core:PlantMachinery 2025-03-04 2026-03-31 16289601 core:Vehicles 2025-03-04 2026-03-31 16289601 core:FurnitureFittings 2025-03-04 2026-03-31 16289601 core:OfficeEquipment 2025-03-04 2026-03-31 16289601 core:NetGoodwill 2025-03-04 2026-03-31 16289601 core:IntangibleAssetsOtherThanGoodwill 2025-03-04 2026-03-31 16289601 core:ListedExchangeTraded 2025-03-04 2026-03-31 16289601 core:UnlistedNon-exchangeTraded 2025-03-04 2026-03-31 16289601 core:MoreThanFiveYears 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments 2026-03-31 16289601 core:Non-currentFinancialInstruments 2025-03-03 16289601 dpl:CostSales 2025-03-04 2026-03-31 16289601 dpl:DistributionCosts 2025-03-04 2026-03-31 16289601 core:LandBuildings 2025-03-04 2026-03-31 16289601 core:PlantMachinery 2025-03-04 2026-03-31 16289601 core:Vehicles 2025-03-04 2026-03-31 16289601 core:FurnitureFittings 2025-03-04 2026-03-31 16289601 core:OfficeEquipment 2025-03-04 2026-03-31 16289601 dpl:AdministrativeExpenses 2025-03-04 2026-03-31 16289601 core:NetGoodwill 2025-03-04 2026-03-31 16289601 core:IntangibleAssetsOtherThanGoodwill 2025-03-04 2026-03-31 16289601 dpl:GroupUndertakings 2025-03-04 2026-03-31 16289601 dpl:ParticipatingInterests 2025-03-04 2026-03-31 16289601 dpl:GroupUndertakings core:ListedExchangeTraded 2025-03-04 2026-03-31 16289601 core:ListedExchangeTraded 2025-03-04 2026-03-31 16289601 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-03-04 2026-03-31 16289601 core:UnlistedNon-exchangeTraded 2025-03-04 2026-03-31 16289601 dpl:CostSales 2025-03-03 2025-03-03 16289601 dpl:DistributionCosts 2025-03-03 2025-03-03 16289601 core:LandBuildings 2025-03-03 2025-03-03 16289601 core:PlantMachinery 2025-03-03 2025-03-03 16289601 core:Vehicles 2025-03-03 2025-03-03 16289601 core:FurnitureFittings 2025-03-03 2025-03-03 16289601 core:OfficeEquipment 2025-03-03 2025-03-03 16289601 dpl:AdministrativeExpenses 2025-03-03 2025-03-03 16289601 core:NetGoodwill 2025-03-03 2025-03-03 16289601 core:IntangibleAssetsOtherThanGoodwill 2025-03-03 2025-03-03 16289601 dpl:GroupUndertakings 2025-03-03 2025-03-03 16289601 dpl:ParticipatingInterests 2025-03-03 2025-03-03 16289601 dpl:GroupUndertakings core:ListedExchangeTraded 2025-03-03 2025-03-03 16289601 core:ListedExchangeTraded 2025-03-03 2025-03-03 16289601 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-03-03 2025-03-03 16289601 core:UnlistedNon-exchangeTraded 2025-03-03 2025-03-03 16289601 core:NetGoodwill 2026-03-31 16289601 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 16289601 core:LandBuildings 2026-03-31 16289601 core:PlantMachinery 2026-03-31 16289601 core:Vehicles 2026-03-31 16289601 core:FurnitureFittings 2026-03-31 16289601 core:OfficeEquipment 2026-03-31 16289601 core:AfterOneYear 2026-03-31 16289601 core:WithinOneYear 2026-03-31 16289601 core:ListedExchangeTraded 2026-03-31 16289601 core:UnlistedNon-exchangeTraded 2026-03-31 16289601 core:ShareCapital 2026-03-31 16289601 core:SharePremium 2026-03-31 16289601 core:RevaluationReserve 2026-03-31 16289601 core:OtherReservesSubtotal 2026-03-31 16289601 core:RetainedEarningsAccumulatedLosses 2026-03-31 16289601 core:NetGoodwill 2025-03-03 16289601 core:IntangibleAssetsOtherThanGoodwill 2025-03-03 16289601 core:LandBuildings 2025-03-03 16289601 core:PlantMachinery 2025-03-03 16289601 core:Vehicles 2025-03-03 16289601 core:FurnitureFittings 2025-03-03 16289601 core:OfficeEquipment 2025-03-03 16289601 core:AfterOneYear 2025-03-03 16289601 core:WithinOneYear 2025-03-03 16289601 core:ListedExchangeTraded 2025-03-03 16289601 core:UnlistedNon-exchangeTraded 2025-03-03 16289601 core:ShareCapital 2025-03-03 16289601 core:SharePremium 2025-03-03 16289601 core:RevaluationReserve 2025-03-03 16289601 core:OtherReservesSubtotal 2025-03-03 16289601 core:RetainedEarningsAccumulatedLosses 2025-03-03 16289601 core:NetGoodwill 2025-03-02 16289601 core:IntangibleAssetsOtherThanGoodwill 2025-03-02 16289601 core:LandBuildings 2025-03-02 16289601 core:PlantMachinery 2025-03-02 16289601 core:Vehicles 2025-03-02 16289601 core:FurnitureFittings 2025-03-02 16289601 core:OfficeEquipment 2025-03-02 16289601 core:AfterOneYear 2025-03-02 16289601 core:WithinOneYear 2025-03-02 16289601 core:ListedExchangeTraded 2025-03-02 16289601 core:UnlistedNon-exchangeTraded 2025-03-02 16289601 core:ShareCapital 2025-03-02 16289601 core:SharePremium 2025-03-02 16289601 core:RevaluationReserve 2025-03-02 16289601 core:OtherReservesSubtotal 2025-03-02 16289601 core:RetainedEarningsAccumulatedLosses 2025-03-02 16289601 core:AfterOneYear 2025-03-04 2026-03-31 16289601 core:WithinOneYear 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:CostValuation 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-04 2026-03-31 16289601 core:Non-currentFinancialInstruments core:CostValuation 2026-03-31 16289601 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-03-31 16289601 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-03-31 16289601 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-03-31 16289601 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-03-31 16289601 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-03-31 16289601 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-03-31 16289601 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-03-31 16289601 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-03-31 16289601 core:Non-currentFinancialInstruments core:CostValuation 2025-03-03 16289601 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-03 16289601 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-03 16289601 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-03 16289601 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-03 16289601 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-03 16289601 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-03 16289601 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-03 16289601 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-03 16289601 bus:Director1 2025-03-04 2026-03-31

AP MEDICAL RESCUE LTD

Registered Number
16289601
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2026

AP MEDICAL RESCUE LTD
Company Information
for the period from 4 March 2025 to 31 March 2026

Director | PEARCE, Andrew Stephen

Registered Address | C/O Roca Accountants Limited, Floor 4 Centenary House
| 1 Centenary Way
| Manchester
| M50 1RF

Registered Number | 16289601 (England and Wales)

AP MEDICAL RESCUE LTD
Balance Sheet as at
31 March 2026

| Notes | 2026
--- | --- | ---
|  | £ |  | £
Current assets |  |  |  |
Debtors | 3 | 4,900 |  |
Cash at bank and on hand |  | 4,241 |  |
|  | 9,141 |  |
Creditors amounts falling due within one year | 4 | (4,257) |  |
Net current assets (liabilities) |  |  |  | 4,884
Total assets less current liabilities |  |  |  | 4,884
Net assets |  |  |  | 4,884
Capital and reserves |  |  |  |
Called up share capital |  |  |  | 1
Profit and loss account |  |  |  | 4,883
Shareholders' funds |  |  |  | 4,884

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 19 May 2026, and are signed on its behalf by:
PEARCE, Andrew Stephen Director Registered Company No. 16289601

AP MEDICAL RESCUE LTD
Notes to the Financial Statements
for the period ended 31 March 2026

1. | Accounting policies
--- | ---

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Judgements and key sources of estimation uncertainty
--- | ---
| In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Revenue from sale of goods
--- | ---
| Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Current taxation
--- | ---
| Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

| Deferred tax
--- | ---
| Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

| Cash and cash equivalents
--- | ---
| Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

2. | Average number of employees
--- | ---

|  | 2026
| Average number of employees during the year | 0

3. | Debtors: amounts due within one year
--- | ---

|  | 2026
--- | --- | ---
|  | £
| Trade debtors / trade receivables | 4,900
| Total | 4,900

4. | Creditors: amounts due within one year
--- | ---

|  | 2026
--- | --- | ---
|  | £
| Bank borrowings and overdrafts | 850
| Taxation and social security | 2,657
| Accrued liabilities and deferred income | 750
| Total | 4,257